These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37304671)

  • 1. Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cells.
    Shahrani MA; Rajagopalan P; Abohassan M; Alshahrani M; Alraey Y; Gahtani RM; Radhakrishnan S; Dagreery K
    Oncol Res; 2021; 29(3):149-157. PubMed ID: 37304671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells.
    Kamli H; Zaman GS; Shaikh A; Mobarki AA; Rajagopalan P
    Oncol Res; 2022 Jan; 28(9):899-911. PubMed ID: 34353411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of second generation benzylidene chromanone analogues as novel, potent DHODH inhibitors in acute myeloid leukemia cells.
    Abohassan M; Al Shahrani M; Rajagopalan P
    J Biomol Struct Dyn; 2023; 41(13):6168-6177. PubMed ID: 35869648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity evaluation and computational analysis identify potent, novel 3-benzylidene chroman-4-one analogs with anti-fungal, anti-oxidant, and anti-cancer activities.
    Zaman GS; Kamli H; Radhakrishnan S; Ahmad I; Otifi H; Alshahrani MY; Rajagopalan P
    Drug Dev Ind Pharm; 2021 Sep; 47(9):1459-1468. PubMed ID: 34726982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GC/MS characterization and computational kinome-wide screening of pomegranate fruit extract identifies key phytochemicals interacting to CDK kinases implicated in acute myeloid leukemia cells.
    Abohassan M; Al Shahrani M; Ahmad I; Abullais SS; Srivastava S; Rajagopalan P
    J Food Biochem; 2022 Aug; 46(8):e14178. PubMed ID: 35451509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations.
    Abohassan M; Alshahrani M; Alshahrani MY; Rajagopalan P
    Med Oncol; 2022 Oct; 39(12):249. PubMed ID: 36209300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways.
    Al Shahrani M; Rajagopalan P; Abohassan M; Alshahrani M; Alraey Y
    Saudi J Biol Sci; 2022 Jun; 29(6):103285. PubMed ID: 35592740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
    Yu K; Wang J; Hou J; Zhang L; Liang H
    Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia.
    Yen SC; Wu YW; Huang CC; Chao MW; Tu HJ; Chen LC; Lin TE; Sung TY; Tseng HJ; Chu JC; Huang WJ; Yang CR; HuangFu WC; Pan SL; Hsu KC
    Phytomedicine; 2022 Jun; 100():154061. PubMed ID: 35364561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
    Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
    J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT.
    Zhou H; Ning Y; Zeng G; Zhou C; Ding X
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.
    Barbarroja N; Torres LA; Rodriguez-Ariza A; Valverde-Estepa A; Lopez-Sanchez LM; Ruiz-Limon P; Perez-Sanchez C; Carretero RM; Velasco F; López-Pedrera C
    Exp Hematol; 2010 Aug; 38(8):641-52. PubMed ID: 20380868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells.
    Davoudi Z; Akbarzadeh A; Rahmatiyamchi M; Movassaghpour AA; Alipour M; Nejati-Koshki K; Sadeghi Z; Dariushnejad H; Zarghami N
    Asian Pac J Cancer Prev; 2014; 15(10):4353-8. PubMed ID: 24935396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.
    Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X
    BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of PI3K/Akt/mTOR Signaling Pathway Inhibitors on the Expression of Immune Checkpoint Ligands in Acute Myeloid Leukemia Cell Line.
    Taghiloo S; Norozi S; Asgarian-Omran H
    Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):178-188. PubMed ID: 35490271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
    Sun X; Yang S; Song W
    Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1.
    Shapourian H; Ghanadian M; Eskandari N; Shokouhi A; Demirel GY; Bazhin AV; Ganjalikhani-Hakemi M
    BMC Cancer; 2024 Jan; 24(1):125. PubMed ID: 38267906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation.
    Zhang S; Zhang Y; Zhuang Y; Wang J; Ye J; Zhang S; Wu J; Yu K; Han Y
    PLoS One; 2012; 7(10):e46853. PubMed ID: 23056487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.